Vandenbark et al., 1989 - Google Patents
Determinants of human myelin basic protein that induce encephalitogenic T cells in Lewis rats.Vandenbark et al., 1989
- Document ID
- 3201662287366501464
- Author
- Vandenbark A
- Hashim G
- Celnik B
- Galang A
- Li X
- Heber-Katz E
- Offner H
- Publication year
- Publication venue
- Journal of immunology (Baltimore, Md.: 1950)
External Links
- 241000700159 Rattus 0 title abstract description 45
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2635444B2 (en) | Treatment of autoimmune diseases by oral administration of autoantibodies | |
| Offner et al. | T cell determinants of myelin basic protein include a unique encephalitogenic IE-restricted epitope for Lewis rats. | |
| KR100216097B1 (en) | T Cell Receptor Peptides for the Treatment of Autoimmune and Malignant Tumor Diseases | |
| Ben-Nun et al. | Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines. | |
| Racke et al. | Copolymer-1-induced inhibition of antigen-specific T cell activation: interference with antigen presentation | |
| CA2188182A1 (en) | Conserved t-cell receptor sequences | |
| Steinman | The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease | |
| Vandenbark et al. | Determinants of human myelin basic protein that induce encephalitogenic T cells in Lewis rats. | |
| JP2009029833A (en) | CD28 / CTLA-4 inhibitory peptide mimetics, pharmaceutical compositions thereof, and methods of using them | |
| Yang et al. | Prevention of adjuvant arthritis in rats by a nonapeptide from the 65-kD mycobacterial heat-shock protein | |
| Hagerty et al. | Intramolecular mimicry. Identification and analysis of two cross-reactive T cell epitopes within a single protein. | |
| JP3434510B2 (en) | Inhibition of T-cell proliferation using peptide fragments of myelin basic protein | |
| AU2238395A (en) | Haptenated peptides and uses thereof | |
| CA2110055C (en) | T cell receptor peptides as therapeutics for immune-related disease | |
| WO1996012737A9 (en) | Compositions and treatment for multiple sclerosis | |
| AU650065B2 (en) | Inhibitor of lymphocyte response and immune-related disease | |
| JP2607751B2 (en) | Treatment and prevention of autoimmune uveitis | |
| WO1997035879A1 (en) | Myelin oligodendrocyte glycoprotein peptides and uses thereof | |
| Offner et al. | Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. I. T cell receptor peptide regulation of T cell clones expressing cross-reactive V beta genes. | |
| Pelfrey et al. | T cell response to two immunodominant proteolipid protein (PLP) peptides in multiple sclerosis patients and healthy controls | |
| Offner et al. | Protection against experimental encephalomyelitis. Idiotypic autoregulation induced by a nonencephalitogenic T cell clone expressing a cross-reactive T cell receptor V gene. | |
| Linington et al. | Induction of experimental allergic neuritis in the BN rat: P2 protein-specific T cells overcome resistance to actively induced disease. | |
| JPH11511129A (en) | HY antigen | |
| JP2010235607A (en) | Peptides as diagnostic and therapeutic agent for autoimmune diseases | |
| Hashim et al. | T cell lines specific for an immunodominant epitope of human basic protein define an encephalitogenic determinant for experimental autoimmune encephalomyelitis-resistant LOU/M rats |